stoxline Quote Chart Rank Option Currency Glossary
  
Merit Medical Systems, Inc. (MMSI)
76.2  -3.93 (-4.9%)    02-29 16:00
Open: 81.15
High: 81.15
Volume: 889,471
  
Pre. Close: 80.13
Low: 75.01
Market Cap: 4,401(M)
Technical analysis
2024-02-29 4:45:06 PM
Short term     
Mid term     
Targets 6-month :  92.22 1-year :  95.07
Resists First :  78.95 Second :  81.4
Pivot price 79.43
Supports First :  75.01 Second :  62.4
MAs MA(5) :  79.27 MA(20) :  79.28
MA(100) :  73.59 MA(250) :  74.68
MACD MACD :  0.2 Signal :  0.5
%K %D K(14,3) :  59.9 D(3) :  69.6
RSI RSI(14): 38.3
52-week High :  85.62 Low :  62.58
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ MMSI ] has closed below the lower bollinger band by 33.4%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 39.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 81.25 - 81.76 81.76 - 82.11
Low: 73.87 - 74.47 74.47 - 74.89
Close: 75.41 - 76.29 76.29 - 76.92
Company Description

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Headline News

Thu, 29 Feb 2024
Merit Medical Systems (NASDAQ:MMSI) PT Raised to $87.00 at Oppenheimer - MarketBeat

Thu, 29 Feb 2024
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q4 2023 Earnings Call Transcript - Insider Monkey

Thu, 29 Feb 2024
Canaccord Genuity Analyst Upgrades Merit Medical Systems to Buy with Increased Price Target - Best Stocks

Thu, 29 Feb 2024
Merit Medical (MMSI) Q4 Earnings Top Estimates, Gross Margin Up - Zacks Investment Research

Thu, 29 Feb 2024
Demystifying Merit Medical Systems: Insights From 5 Analyst Reviews - Markets Insider

Thu, 29 Feb 2024
Q4 2023 Merit Medical Systems Inc Earnings Call Transcript - GuruFocus.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Shares Out 58 (M)
Shares Float 56 (M)
Held by Insiders 2.2 (%)
Held by Institutions 101.2 (%)
Shares Short 2,230 (K)
Shares Short P.Month 2,120 (K)
Stock Financials
EPS 1.72
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 21.29
Profit Margin 8.1 %
Operating Margin 11.3 %
Return on Assets (ttm) 4.5 %
Return on Equity (ttm) 8.6 %
Qtrly Rev. Growth 9.8 %
Gross Profit (p.s.) 0
Sales Per Share 21.29
EBITDA (p.s.) 3.68
Qtrly Earnings Growth 63.7 %
Operating Cash Flow 111 (M)
Levered Free Cash Flow 51 (M)
Stock Valuations
PE Ratio 44.3
PEG Ratio 2.3
Price to Book value 3.57
Price to Sales 3.57
Price to Cash Flow 39.67
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android